Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Allred

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Human Pathology|April 1, 1993
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinomaR W Brown, G M Clark, A K Tandon, et al.
Archives of Pathology & Laboratory Medicine|September 26, 2001
Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomasM R Foster, J E Johnson, S J Olson, et al.
Journal of the National Cancer Institute|October 16, 1991
Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifenC K Osborne, E Coronado, D C Allred, et al.
Breast Cancer Research and Treatment|January 1, 1994
Molecular genetic studies of early breast cancer evolutionP O'Connell, V Pekkel, S Fuqua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancerJ M Harvey, G M Clark, C K Osborne, et al.
Cancer Research|July 15, 1993
p53 is mutated in a subset of advanced-stage prostate cancersR Bookstein, D MacGrogan, S G Hilsenbeck, et al.
Proceedings of the Association of American Physicians|December 12, 1997
Insulin receptor expression and clinical outcome in node-negative breast cancerM C Mathieu, G M Clark, D C Allred, et al.
Clinical Immunology and Immunopathology|January 1, 1991
A comparison of foreign body and hypersensitivity granuloma formation in the mouse: kinetic development, anergy, angiotensin converting enzyme levels, and response to captopril therapyC H Stone, D C Allred, B L Oliver, et al.
Breast Cancer Research and Treatment|January 1, 1993
William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancerR M Elledge, S A Fuqua, G M Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
p53 mutation and tamoxifen resistance in breast cancerR M Elledge, S Lock-Lim, D C Allred, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Human Pathology|April 1, 1993
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinomaR W Brown, G M Clark, A K Tandon, et al.
Archives of Pathology & Laboratory Medicine|September 26, 2001
Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomasM R Foster, J E Johnson, S J Olson, et al.
Journal of the National Cancer Institute|October 16, 1991
Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifenC K Osborne, E Coronado, D C Allred, et al.
Breast Cancer Research and Treatment|January 1, 1994
Molecular genetic studies of early breast cancer evolutionP O'Connell, V Pekkel, S Fuqua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancerJ M Harvey, G M Clark, C K Osborne, et al.
Cancer Research|July 15, 1993
p53 is mutated in a subset of advanced-stage prostate cancersR Bookstein, D MacGrogan, S G Hilsenbeck, et al.
Proceedings of the Association of American Physicians|December 12, 1997
Insulin receptor expression and clinical outcome in node-negative breast cancerM C Mathieu, G M Clark, D C Allred, et al.
Clinical Immunology and Immunopathology|January 1, 1991
A comparison of foreign body and hypersensitivity granuloma formation in the mouse: kinetic development, anergy, angiotensin converting enzyme levels, and response to captopril therapyC H Stone, D C Allred, B L Oliver, et al.
Breast Cancer Research and Treatment|January 1, 1993
William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancerR M Elledge, S A Fuqua, G M Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
p53 mutation and tamoxifen resistance in breast cancerR M Elledge, S Lock-Lim, D C Allred, et al.
Pageof 8